NDA[removed]S-027 FDA Approved Labeling Text dated[removed]Page 1 1 2

First Page		Document Content
Date: 2012-09-06 14:05:10 Chemistry Felbamate Phenytoin Valproic acid Lennox–Gastaut syndrome Carbamazepine Aplastic anemia Absence seizure Phenobarbital Anticonvulsants Medicine Epilepsy		NDA[removed]S-027 FDA Approved Labeling Text dated[removed]Page 1 1 2 Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 317,90 KB Share Document on Facebook

	Articles Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials Philippe Ryvlin*, Michel Cuchera DocID: 1pxrC - View Document
	FELBATOL ® (felbamate) Tablets 400 mg and 600 mg, DocID: 1lqps - View Document
	HK J Paediatr (new series) 2005;10:[removed]Original Articles Epilepsy in Women: Role of Paediatricians KY LAU, KL KWONG DocID: Vrih - View Document
	FELBATOL ® (felbamate) Tablets 400 mg and 600 mg, DocID: RXPd - View Document
	CARBATROL® (carbamazepine) Extended-Release Capsules 100 mg, 200 mg and 300 mg Rx only Prescribing information DocID: Nu1V - View Document